MedCity News
Vaccine rollout is an administrative problem, not a distribution issue and is expected to go away
The CEOs of Pfizer, Moderna, McKesson and CVS Health explained that the distribution effort has gone well but the administration of the vaccine has now to catch up. They expect it to happen soon.
Shares1
Chief executives of the companies that have led the charge in developing vaccines for Covid-19 and their distribution were unanimous in their assessment Wednesday that the vaccine rollout problems were temporary and would recede fairly quickly. They were all speaking on a panel at the third day of the virtual J.P. Morgan Healthcare Conference.
Moderna Vaccine May Work for a Couple of Years By Ralph Ellis
Jan. 8, 2021 The Moderna vaccine one of two vaccines now being distributed in the United States will “potentially” provide protection against COVID-19 for several years, the biotech company’s CEO said, according to Reuters.
But Stephane Bancel said the Massachusetts-based Moderna will have to conduct more research to be definitive about how long the vaccine will work. Because coronavirus vaccines are new, health experts aren’t sure how long they’ll be effective.
“The nightmare scenario that was described in the media in the spring with a vaccine only working a month or two is, I think, out of the window,” Bancel said at an event organized by the Franco-German financial services group Oddo BHF.